Tarsa Therapeutics

Board Description

Tarsa Therapeutics is developing OSTORA, an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.

Industry
Pharmaceuticals
Country
United States
State
Pennsylvania